Prenetics Global Limited reported $31M of revenue over the trailing twelve months, +41% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $31M (to FY2024). Net income: −$46M, trailing twelve months to FY2024. Free cash flow: −$30M, trailing twelve months to FY2024. Operating margin: −157%, trailing twelve months to FY2024.

PREPrenetics Global Limited

Healthcare

$22.08+54% 1Y

$22.08

$11.7952 weeks$26.30

PRE as reported

Prenetics Global Limited reported $31M of revenue over the trailing twelve months, +41% on the year before. 9 reported series are charted on this page, each one as filed.

$31M

Revenue, trailing twelve months · to FY2024 · +41% against the twelve months before

Net income: −$46M
Net income · −26% year on year · trailing twelve months to FY2024
Free cash flow: −$30M
Free cash flow · +112% year on year · trailing twelve months to FY2024
Operating margin: −157%
Operating margin · trailing twelve months to FY2024

Details›

Every series Ryufin has for PRE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$31M	+41%	FY2024
Net income	−$46M	−26%	FY2024
EPS	−$3.71	−34%	FY2024
Gross margin	50%	n/a	FY2024
Operating margin	−157%	n/a	FY2024
Net margin	−151%	n/a	FY2024
ROE	−27%	n/a	FY2024
ROA	−22%	n/a	FY2024
Free cash flow	−$30M	+112%	FY2024

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.